Company intelligence / Profile preview

DNAe

London, United Kingdomdnae.com ↗

Ownership: Private
Development stage: Preclinical

Overview

DNAe has developed a proprietary semiconductor-based next-generation sequencing platform called LiDia‑SEQ™, capable of rapid direct-from-specimen genomic analysis. Its lead product focuses on diagnosing bloodstream infections and antimicrobial resistance directly from whole blood within hours—significantly faster than traditional culture methods. The company’s technology has demonstrated the ability to detect pathogens at very low concentrations in blood samples. Clinical studies have shown successful completion of early phases under BARDA contracts, with further clinical validation ongoing for regulatory submission.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Device (diagnostic platform)Nucleic acid detection technologyNext-generation sequencing (NGS) platformSemiconductor-based diagnostic system
Industry: Molecular Diagnostics

Partnerships

BARDA/HHSThermo Fisher Scientific/Ion Torrent

Beyond the preview

Go deeper on DNAe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNAe.

Explore the full profile